From July 3, 2023 to September 30, 2023, the company has repurchased 731,500 shares, representing 0.08% for CNY 20.1 million. With this, the company has completed the repurchase of 731,500 shares, representing 0.08% for CNY 20.1 million under the buyback announced on July 4, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
41.63 CNY | -1.49% | +1.19% | +32.45% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+32.45% | 5.31B | |
+30.38% | 684B | |
+29.55% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.36% | 240B | |
+9.43% | 208B | |
-7.32% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- 600566 Stock
- News Hubei Jumpcan Pharmaceutical Co., Ltd.
- Tranche Update on Hubei Jumpcan Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 4, 2023.